Evidence map›Paper›PMID 28281401›Full record

ArticleXenobiotica; the fate of foreign compounds in biological systems2018

A novel in vitro allometric scaling methodology for aldehyde oxidase substrates to enable selection of appropriate species for traditional allometry.

Rachel D Crouch, J Matthew Hutzler, J Scott Daniels

Open access · greenAbstract read
In one paragraph

Article in Xenobiotica; the fate of foreign compounds in biological systems, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.0field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 21 citations in OpenAlex.

  1. Article
  2. Review
  3. Enzyme Kinetics, Pharmacokinetics, and Inhibition of Aldehyde Oxidase.Methods in molecular biology (Clifton, N.J.) · 2021
    Article
  4. Article
  5. Time Course of Aldehyde Oxidase and Why It Is Nonlinear.Drug metabolism and disposition: the biological fate of chemicals · 2019
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Rachel D Croucha Department of Pharmacology , Vanderbilt University School of Medicine , Nashville , TN , USA and.
J Matthew Hutzlerb Q2 Solutions, Bioanalytical and ADME Labs , Indianapolis , IN , USA.
J Scott Danielsa Department of Pharmacology , Vanderbilt University School of Medicine , Nashville , TN , USA and.
Vanderbilt University · USQ2 Solutions (United States) · US

Funding

TRAINING IN PHARMACOLOGICAL SCIENCEST32GM007628 · NIGMS · VANDERBILT UNIVERSITY · PI BARNETT, JOEY VICTOR, KAVALALI, EGE T · 1985 to 2022
$11.2M
NIGMS NIH HHS T32 GM007628
6 · The paper itself

Abstract

1. Failure to predict human pharmacokinetics of aldehyde oxidase (AO) substrates using traditional allometry has been attributed to species differences in AO metabolism. 2. To identify appropriate species for predicting human in vivo clearance by single-species scaling (SSS) or multispecies allometry (MA), we scaled in vitro intrinsic clearance (CL

Indexed as

PharmacokineticsAcetamidesAldehyde OxidaseAnimalsFemaleGuanidinesGuanineGuinea PigsHumansLiverMacaca fascicularisMacaca mulattaMaleMicePyrazolesPyridazines6-(6-(1-methyl-1H-pyrazol-4-yl)-(1,2,4)triazolo(4,3-b)pyridazin-3-ylsulfanyl)quinolineAcetamidesAldehyde OxidaseGuanidinesGuanineO(6)-benzylguaninePyrazolesPyridazinesPyrimidinesTriazoleszaleplonzoniporideAldehyde oxidaseclearancedrug metabolismmolybdenum hydroxylasenoncytochrome P450pharmacokineticsS9species differences

Identifiers

PMID28281401
PMCPMC6207370
OpenAlexW2589072694

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.